Pädiatrie up2date 2014; 09(03): 291-305
DOI: 10.1055/s-0034-1377614
Atemwegserkrankungen
© Georg Thieme Verlag KG Stuttgart · New York

Giemen und Brummen – Differenzialdiagnose obstruktiver Atemwegserkrankungen der unteren Atemwege

Johannes H. Wildhaber
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
19. August 2014 (online)

Zusammenfassung

Zusammenfassend lässt sich feststellen, dass das komplexe Feld der Atemwegserkrankungen einer genauen Beschreibung bzw. Diagnose bedarf, um eine adäquate Therapieform wählen zu können.

 
  • Literatur

  • 1 Brand PL, Baraldi E, Bisgaard H et al. Definition, assessment and treatment of wheezing disorders in preschool children. Eur Respir J 2008; 32: 1096-1110
  • 2 Piedimonti G. Pathophysiological mechanisms fort he respiratory syncytial virus-reactive airway disease link. Respir Res 2002; S21-S25
  • 3 Martinez FD, Wright AL, Taussig LM et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133-138
  • 4 Castro-Rodriguez JA, Holberg CJ, Wright AL et al. A clinical index to define risk of asthmas in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 1403-1406
  • 5 Guilbert TW, Morgan WJ, Zeiger R et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985-1997
  • 6 Leonardi NA, Spycher BD, Strippoli MP et al. Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. J Allergy Clin Immunol 2011; 127: 1466-1472
  • 7 Frey U, Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet 2008; 372: 1088-1099
  • 8 Bonnelykke K, Sleiman P, Nielsen K et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with sever exacerbations. Lancet 2013; 10: 1038
  • 9 Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in acomplex, heterogenous disease. Lancet 2008; 372: 1107-1119
  • 10 Propp P, Becker A. Prevention of asthma: where are we in the 21st century?. Expert Rev Clin Immunol 2013; 9: 1267-1278
  • 11 Singer F, Latzin P. Exhaled NO in infants – a marker of inflammation?. Eur Respir Soc Monograph 2010; 49: 56-70
  • 12 Singer F, Luchsinger I, Inci D et al. Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma. Allergy 2013; 68: 531-538
  • 13 Sorkness CA, Lemanske Jr RF, Mauger DT et al. Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Long-term comparison of 3 controller regimens for mild-modearte persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007; 119: 64-72
  • 14 Chang AB, Redding GJ, Everard ML. Chronic wet cough: Protracted bronchitis, chronic supporative lung disease and bronchiectasis. Pediatr Pulmonol 2008; 43: 519-531